135 related articles for article (PubMed ID: 2838166)
21. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
[TBL] [Abstract][Full Text] [Related]
22. The accessory cell function of human alveolar macrophages in specific T cell proliferation.
Toews GB; Vial WC; Dunn MM; Guzzetta P; Nunez G; Stastny P; Lipscomb MF
J Immunol; 1984 Jan; 132(1):181-6. PubMed ID: 6228577
[TBL] [Abstract][Full Text] [Related]
23. Generation of superoxide anion by alveolar macrophages in sarcoidosis: evidence for the activation of the oxygen metabolism in patients with high-intensity alveolitis.
Cassatella MA; Berton G; Agostini C; Zambello R; Trentin L; Cipriani A; Semenzato G
Immunology; 1989 Mar; 66(3):451-8. PubMed ID: 2539325
[TBL] [Abstract][Full Text] [Related]
24. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
[TBL] [Abstract][Full Text] [Related]
25. Kinetics and function of tumor cytotoxic factor(s) produced by human blood monocytes activated to the tumoricidal state.
Sone S; Lopez-Berestein G; Fidler IJ
J Natl Cancer Inst; 1985 Mar; 74(3):583-90. PubMed ID: 3856062
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Utsugi T; Sone S
J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
[TBL] [Abstract][Full Text] [Related]
27. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma.
Murray HW; Gellene RA; Libby DM; Rothermel CD; Rubin BY
J Immunol; 1985 Oct; 135(4):2374-7. PubMed ID: 3928746
[TBL] [Abstract][Full Text] [Related]
28. Activation of tumoricidal properties in peripheral blood monocytes of patients with colorectal carcinoma.
Fidler IJ; Jessup JM; Fogler WE; Staerkel R; Mazumder A
Cancer Res; 1986 Feb; 46(2):994-8. PubMed ID: 3000591
[TBL] [Abstract][Full Text] [Related]
29. Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells.
Rüegg SJ; Jungi TW
Immunology; 1988 Mar; 63(3):513-20. PubMed ID: 2965100
[TBL] [Abstract][Full Text] [Related]
30. Subcutaneously administered recombinant interferon-gamma in humans: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages, blood neutrophils, and monocytes.
Halme M; Maasilta P; Repo H; Leirisalo-Repo M; Taskinen E; Mattson K; Cantell K
J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):283-91. PubMed ID: 8061901
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity of tumoricidal function in macrophages from different anatomical sites of cancer patients to modulation of arachidonic acid metabolism.
Braun DP; Ahn MC; Harris JE; Chu E; Casey L; Wilbanks G; Siziopikou KP
Cancer Res; 1993 Jul; 53(14):3362-8. PubMed ID: 8391924
[TBL] [Abstract][Full Text] [Related]
32. Innate-immune therapy for lung carcinoma based on tissue-macrophage activation with lipopolysaccharide.
Hino M; Kohchi C; Nishizawa T; Yoshida A; Nakata K; Inagawa H; Hori H; Makino K; Terada H; Soma G
Anticancer Res; 2005; 25(6A):3747-54. PubMed ID: 16302735
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
Sampson-Johannes A; Carlino JA
J Immunol; 1988 Nov; 141(10):3680-6. PubMed ID: 3053901
[TBL] [Abstract][Full Text] [Related]
34. Role of antitumor activity of alveolar macrophages in lung cancer patients.
Kuda T; Yasumoto K; Yano T; Nakahashi H; Sugimachi K; Nomoto K
Cancer Res; 1987 Apr; 47(8):2199-202. PubMed ID: 3829005
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of macrophage and monocyte cytotoxicity by the surface active material of lung lining fluid.
Baughman RP; Mangels DJ; Strohofer S; Corser BC
J Lab Clin Med; 1987 Jun; 109(6):692-7. PubMed ID: 3585142
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes.
Murray HW; Scavuzzo D; Jacobs JL; Kaplan MH; Libby DM; Schindler J; Roberts RB
J Immunol; 1987 Apr; 138(8):2457-62. PubMed ID: 3104467
[TBL] [Abstract][Full Text] [Related]
37. Tumor killing by human alveolar macrophages and blood monocytes. Decreased cytotoxicity of human alveolar macrophages.
Weissler JC; Lipscomb MF; Lem VM; Toews GB
Am Rev Respir Dis; 1986 Sep; 134(3):532-7. PubMed ID: 3019195
[TBL] [Abstract][Full Text] [Related]
38. Phagocytosis induction of chemiluminescence and chemoattractant increased superoxide anion release from activated human alveolar macrophages in asthma.
Damon M; Cluzel M; Chanez P; Godard P
J Biolumin Chemilumin; 1989 Jul; 4(1):279-86. PubMed ID: 2552756
[TBL] [Abstract][Full Text] [Related]
39. Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages.
Ockenhouse CF; Schulman S; Shear HL
J Immunol; 1984 Sep; 133(3):1601-8. PubMed ID: 6431003
[TBL] [Abstract][Full Text] [Related]
40. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
